The largest database of trusted experimental protocols

16 protocols using polyinosinic polycytidylic acid pipc

1

Conditional hRasGRP1 Expression Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression construct was generated by cloning the various components into targeting ROSA vector (ROSA-HR). Vector was obtained by introducing first a flanked Neo/STOP cassette and then the hRasGRP1 cDNA cassette, IRES-EGFP, and human polA sequences into a Rosa26 targeting vector that already contain a ubiquitous CAG promoter cassette (Figure. 1A). This construct was transfected into ES cells by electroporation in optimized condition (5×106 cells in presence of 40 μg linearized plasmid, 260V, 500 uF). Positive selection started 48 h after electroporation by adding 200 μg/ml of G418 in 96-well plates. Positive clones were further screened by southern blotting. Furthermore, the hybridization with internal probe did not indicate that any of the ES cells screened contained an additional randomly integrated copy of the targeting plasmid. At the age of 4 weeks mice received a single intraperitoneal injection of polyinosinic-polycytidylic acid (pIpC) (1μg/250μl/mouse) (Sigma, San Luis, MO, US) to induce the expression of hRASGRP1 and GFP from the Rosa26 locus.
+ Open protocol
+ Expand
2

Conditional Deletion of Dnmt3a/3b in HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal procedures were IACUC-approved and conducted in accordance the Baylor College of Medicine and Washington University in St. Louis institutional guidelines. All mice were C57Bl/6 background distinguished by CD45.1 or CD45.2 alleles. Dnmt3afl/fl and Dnmt3bfl/fl mice were obtained from the Beaudet lab at Baylor College of Medicine (with the consent of En Li) and crossed to Mx1-cre mice. For bone marrow transplantation, recipient C57Bl/6 CD45.1 mice were transplanted by retroorbital injection following a split dose of 10.5 Gy of lethal irradiation. 250 donor HSCs (CD45.2) were competed against 2.5 × 105 WBM cells with the opposite CD45 allele (matched to the recipient). In competitive transplantation experiments, deletion of floxed alleles in donor HSCs was mediated 5–6 weeks post-transplantation in primary recipients. Conditional deletion was mediated by six intraperitoneal injections (300µg / mouse) of polyinosinic-polycytidylic acid (pIpC; Sigma, St Louis, MO) in PBS every other. For serial HSC transplantation, WBM from transplanted recipients was isolated 18-weeks post-transplant and donor HSCs were re-purified using CD45.2+SPKLS gating. 250 of these re-purified donor HSCs were competed against 2.5 × 105 fresh CD45.1 WBM. PCR screening of Dnmt3a and Dnmt3b floxed allele deletion was performed as previously described (Tadokoro et al., 2007 (link)).
+ Open protocol
+ Expand
3

Conditional Knockout of Dnmt3a and Dnmt3b in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) and conducted in accordance with Washington University School of Medicine institutional guidelines. Mice were C57Bl/6 background, Mx1-Cre:Dnmt3afl/fl and Mx1-Cre:Dnmt3afl/fl;Dnmt3bfl/fl mice have been described (16 ). Recombination of floxed alleles was mediated by six intraperitoneal injections (300μg/mouse) of polyinosinic-polycytidylic acid (pIpC; Sigma, St. Louis, MO, USA) in PBS every other day. The following strains were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) - Lck-CRE (003802), CD8a-CRE (008766), Rosa26NICD (008159), Rosa26EYFP (006148) and Nr4a1KO (006187).
+ Open protocol
+ Expand
4

Conditional Deletion of hnRNP L in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
hnRNP L floxed mice were described previously26 (link). MxCre, VavCre, H2kBcl2 and Trp53−/− mice were obtained from Jackson laboratories or from a colony maintained at the IRCM. The animal ethics committee of the IRCM approved all animal experiments. MxCre+hnRNP Lfl/fl or hnRNP Lfl/fl mice were injected intraperitoneally with 500 μg of polyinosinic-polycytidylic acid (pIpC; Sigma-Aldrich) every other day for a total of 5 times and were analyzed 14 days after the first injection. All mice were aged between 8–16 weeks for BM analysis.
+ Open protocol
+ Expand
5

Conditional Yy1 Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Yy1f/f mice (Affar et al., 2006 (link); Liu et al., 2007 (link)) in which the Yy1 promoter region and exon 1 are flanked by loxP sites, were crossed to Mx1-Cre mice to generate heterozygous Yy1f/+Mx1-cre mice. Yy1f/+Mx1-cre mice were then subsequently bred with Yy1f/f mice to generate homozygous Yy1f/fMx1-cre mice. To induce the expression of Cre recombinase, 6- to 8-week-old mice were injected with 200 mg of polyinosinic-polycytidylic acid (pI-pC; Sigma-Aldrich) every other day for 5 doses. Approximately equal portions of mice of both genders were used, and aggregated data are presented because gender specific differences were not found. All experiments described in this manuscript were performed 7–10 days after the last injection of pI-pC unless stated otherwise. All experiments involving mice were approved by the Institutional Laboratory Animal Care and Use Committee of the University of Wisconsin-Madison and conform to the appropriate regulatory standards.
+ Open protocol
+ Expand
6

IGF-I Knockout Mice Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LI-IGF-I−/− mice on a C57BL/6 background were generated as described previously [1 (link), 2 (link)]. Mice homozygous for LoxP [26 (link)] and hemizygous for Mx-Cre [27 (link)] received three ip injections of polyinosinic-polycytidylic acid (PiPc; 6.25 µg/g body weight; Sigma-Aldrich Corp., Stockholm, Sweden) at 3 months of age to induce expression of the Cre protein, thereby inactivating the IGF-I gene in the liver [27 (link)]. PiPc-treated female and male littermates, homozygous for LoxP but lacking Mx-Cre, were used as controls as previously described [2 (link), 3 (link), 26 (link)]. Seven days after the PiPc injections as well as at the end of the study, serum was obtained and assayed for IGF-I by a double-antibody IGF-binding protein-blocked RIA (Mediagnost, Tübingen, Germany). The mice were housed in a standard animal facility under controlled temperature (22 °C) and photoperiod (12 h of light, 12 h of dark) with free access to water and food pellets (B&K Universal AB, Sollentuna, Sweden). Animal care was in accordance with institutional guidelines. The ethical committee at the University of Gothenburg approved this study.
+ Open protocol
+ Expand
7

Conditional hRasGRP1 Expression Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression construct was generated by cloning the various components into targeting ROSA vector (ROSA-HR). Vector was obtained by introducing first a flanked Neo/STOP cassette and then the hRasGRP1 cDNA cassette, IRES-EGFP, and human polA sequences into a Rosa26 targeting vector that already contain a ubiquitous CAG promoter cassette (Figure. 1A). This construct was transfected into ES cells by electroporation in optimized condition (5×106 cells in presence of 40 μg linearized plasmid, 260V, 500 uF). Positive selection started 48 h after electroporation by adding 200 μg/ml of G418 in 96-well plates. Positive clones were further screened by southern blotting. Furthermore, the hybridization with internal probe did not indicate that any of the ES cells screened contained an additional randomly integrated copy of the targeting plasmid. At the age of 4 weeks mice received a single intraperitoneal injection of polyinosinic-polycytidylic acid (pIpC) (1μg/250μl/mouse) (Sigma, San Luis, MO, US) to induce the expression of hRASGRP1 and GFP from the Rosa26 locus.
+ Open protocol
+ Expand
8

Conditional Deletion of miR-21 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal, wild-type (WT) C57BL/6J mice were purchased from the Institute of Zoology (Chinese Academy of Sciences, Beijing, China). miR-21flox/+ (miR-21fl/+) mice and Mx1-Cre mice were obtained from Shanghai Model Organisms Center (China). miR- 21fl/fl;Mx1-Cre mice were generated by crossing miR-21fl/fl mice with Mx1-Cre mice. Unless otherwise stated, miR-21 deletion was induced by intraperitoneally injecting 4- to 6-week old miR- 21fl/fl;Mx1-Cre+mice with 250 g of polyinosinic:polycytidylic acid (pIpC) (Sigma, St. Louis, MO, USA) every other day for a total of seven doses. Four weeks after pIpC treatment, these mice were used in subsequent experiments. Identically treated miR- 21fl/fl;Mx1-Cre- littermates served as controls. Congenic C57Bl/6 SJL CD45.1+ mice were kindly provided by Prof. Jinyong Wang (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China). All animal experiments were approved by the Animal Care Committee of The Third Military Medical University (Chongqing, China).
+ Open protocol
+ Expand
9

Conditional Deletion of Fbxo22 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fbxo22fl/fl mice and C57BL/6 Bach1 knockout mice were established at the Cyagen Biosciences Inc. Fbxo22fl/fl mice were further crossed with Myxovirus resistance protein 1 (Mx1)-Cre or stem cell leukemia stem-cell enhancer (Scl)-Cre transgenic mice to achieve specifically inducible deletion of Fbxo22 in hematopoietic cells. All these strains were maintained on a C57BL/6 background. To induce Mx1-Cre recombinase, polyinosinic–polycytidylic acid (pIpC, Sigma, 1 mg/ml in distilled water) was administered at 10 µg/g body weight every other day by intraperitoneal injection for 7 times; to induce Scl-Cre recombinase, tamoxifen (Sigma, 10 mg/ml in corn oil) was administered at 50 µg/g body weight daily by intraperitoneal injection for 21 days. All the animal experiments were approved by our institution and conducted according to the Guideline for Animal Care at Shanghai Jiao Tong University School of Medicine.
+ Open protocol
+ Expand
10

Conditional Yy1 Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Yy1f/f mice (Affar et al., 2006 (link); Liu et al., 2007 (link)) in which the Yy1 promoter region and exon 1 are flanked by loxP sites, were crossed to Mx1-Cre mice to generate heterozygous Yy1f/+Mx1-cre mice. Yy1f/+Mx1-cre mice were then subsequently bred with Yy1f/f mice to generate homozygous Yy1f/fMx1-cre mice. To induce the expression of Cre recombinase, 6- to 8-week-old mice were injected with 200 mg of polyinosinic-polycytidylic acid (pI-pC; Sigma-Aldrich) every other day for 5 doses. Approximately equal portions of mice of both genders were used, and aggregated data are presented because gender specific differences were not found. All experiments described in this manuscript were performed 7–10 days after the last injection of pI-pC unless stated otherwise. All experiments involving mice were approved by the Institutional Laboratory Animal Care and Use Committee of the University of Wisconsin-Madison and conform to the appropriate regulatory standards.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!